Detection of biotin-streptavidin interactions via terminal protection of small molecule linked DNA and the formation of fluorescent DNA-templated silver nanoclusters

被引:0
作者
Yue He
Bining Jiao
机构
[1] Southwest University,Laboratory of Quality & Safety Risk Assessment for Citrus Products (Chongqing), Ministry of Agriculture, Citrus Research Institute
[2] National Citrus Engineering Research Center,undefined
来源
Microchimica Acta | 2016年 / 183卷
关键词
Bioassay; Biosensor; Nanomaterial; Exonuclease I; C-rich DNA; Enzymatic hydrolysis; Digestion; Biotinylated DNA; Label free; Fluorescence;
D O I
暂无
中图分类号
学科分类号
摘要
It is known that the binding of certain proteins to small molecules in ssDNA/small-molecule chimeras protects the conjugated ssDNA from degradation by exonuclease I (Exo I). This has resulted in numerous methods to specifically detect the interaction between small molecules and proteins. We are presenting here an approach that utilizes the terminal protection strategy in combination with the formation of ssDNA-templated silver nanoclusters (AgNCs), thereby providing a fluorometric tool for the detection of such interactions. A C-rich ssDNA (type 5′-CCCCACCCCT-3′) was labelled with biotin at the 3′ end. In the absence of streptavidin (SA), the biotinylated ssDNA is hydrolyzed in the 3′ to 5′ direction by Exo I to form mononucleotides. The formation of the AgNCs is prevented due to the lack of the DNA scaffold, and this results in weak fluorescence. Conversely, in the presence of SA, the specific binding of SA to the biotinylated ssDNA protects the ssDNA from digestion. As a result, fluorescent AgNCs are being formed. Fluorescence is measured at excitation/emission wavelengths of 625/705 nm. The calibration plot for SA is linear in the 6 to 600 nM concentration range, with a 2.6 nM detection limit. The assay is simple, sensitive and affordable. Conceivably, the method may also be used to detect the binding of other small molecules to proteins.
引用
收藏
页码:3183 / 3189
页数:6
相关论文
共 194 条
  • [1] Michnick SW(2007)Universal strategies in research and drug discovery based on protein-fragment complementation assays Nat Rev Drug Discov 6 569-582
  • [2] Ear PH(2004)Exploring biology with small organic molecules Nature 432 846-854
  • [3] Manderson EN(2003)From knowing to controlling: a path from genomics to drugs using small molecule probes Science 300 294-295
  • [4] Remy I(2002)Optical biosensors in drug discovery Nat Rev Drug Discov 1 515-528
  • [5] Stefan E(1996)A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p Science 272 408-411
  • [6] Stockwell BR(2005)Kinetic capillary electrophoresis (KCE): a conceptual platform for kinetic homogeneous affinity methods J Am Chem Soc 127 17104-17110
  • [7] Strausberg RL(2009)Selection of smart small-molecule ligands: the proof of principle Anal Chem 81 490-494
  • [8] Schreiber SL(2005)Label-free detection of small-molecule-protein interactions by using nanowire nanosensors Proc Natl Acad Sci U S A 102 3208-3212
  • [9] Cooper MA(1997)A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets Proc Natl Acad Sci U S A 94 13396-13401
  • [10] Taunton J(2006)Visualization of molecular interactions by fluorescence complementation Nat Rev Mol Cell Biol 7 449-456